Dapagliflozin’s CKD performance sends heart failure messagesOctober 5, 2020DiabetesEndocrinologyCardiologyNephrology
AHA scientific statement highlights cardiorenal benefit of new diabetes drugsOctober 1, 2020DiabetesCardiologyEndocrinology
New data challenge primary care’s inattention to aldosterone in hypertensionOctober 1, 2020CardiologyEndocrinology
Higher glycemic time in range may benefit T2D patientsSeptember 28, 2020DiabetesCardiologyEndocrinology
Exercise cuts diabetes death risk by a third in two studiesSeptember 28, 2020DiabetesCardiologyEndocrinology
DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor useSeptember 25, 2020DiabetesMixed TopicsNephrologyEndocrinologyCardiology
Treat-to-target strategy ‘not ready for primetime’ in osteoporosisSeptember 18, 2020EndocrinologyRheumatology
More dairy lowers risk of falls, fractures in frail elderlySeptember 16, 2020GeriatricsRheumatologyEndocrinologyGeriatrics
Mega vitamin D harms bone in women, not men, without osteoporosisSeptember 15, 2020EndocrinologyRheumatologyWomen's Health
More U.S. states cap insulin cost, but activists will ‘fight harder’September 9, 2020DiabetesEndocrinology
CagA-positive H. pylori patients at higher risk of osteoporosis, fractureSeptember 1, 2020RheumatologyEndocrinologyGastroenterology
Obesity boosts risks in COVID-19 from diagnosis to deathSeptember 1, 2020ObesityCOVID-19 UpdatesEndocrinology
Gut bacteria linked to cardiovascular, other health conditionsAugust 31, 2020DiabetesEndocrinologyCardiology
DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetesAugust 31, 2020DiabetesCardiologyNephrologyEndocrinology
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit solidifies class effectsAugust 30, 2020DiabetesCardiologyEndocrinology
